Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001370259.2(MEN1):c.1401C>T(p.Ala467Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,596,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A467A) has been classified as Likely benign.
MEN1 (HGNC:7010): (menin 1) This gene encodes menin, a tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. Menin is a scaffold protein that functions in histone modification and epigenetic gene regulation. It is thought to regulate several pathways and processes by altering chromatin structure through the modification of histones. [provided by RefSeq, May 2019]
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 11-64804766-G-A is Benign according to our data. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804766-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 241805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.22 with no splicing effect.
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 05, 2024
Myriad Genetics, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -
not providedBenign:2
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
MEN1: BP4, BP7 -
Oct 09, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specifiedBenign:1
Jun 06, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
MEN1-related disorderBenign:1
Jul 13, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hereditary cancer-predisposing syndromeBenign:1
Oct 16, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -